PFE Today - Aug 06: Earnings Beat, Stock Still Slips

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

PFE Today - Aug 06: Earnings Beat, Stock Still Slips

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor, breaking down what went down with Pfizer today. So, PFE had a bit of a red day, barely up at 0.62%.

Now, here’s the scoop. Pfizer’s been all over the place lately. They reported earnings that actually beat expectations, which usually gives stocks a nice little boost, right? But instead of soaring, it kinda just hung around. People were hitting the sell button, probably because they saw some big red flags. One of their COVID drugs saw revenue drop a whopping 95%. Yeah, that one stung.

Despite the earnings beat, there were some concerns about their future growth, especially with their obesity drugs not hitting the mark like they hoped. It’s like, they’re trying to pivot, but the market's not fully buying it, you know? They’re also making some big cuts – like $2.5 billion worth – which sounds good on paper but can freak investors out. It’s like, "What’s going on behind the scenes?"

But hey, on the bright side, they’re still churning out cash, which is a good thing for shareholders. It’s kinda like a mixed bag right now. Some folks are optimistic, while others are a bit jittery.

Oh, and just so you know, Pfizer’s trading at a premium even though it’s seen a 27% drop over the last five years. That’s a long haul, but it shows some resilience.

So, in a nutshell, Pfizer had a rough day even with some decent earnings. There are definitely some things to keep an eye on as they navigate these choppy waters.

That’s it for today! Just remember, this is all for fun and info, not financial advice. Catch you later!

まだレビューはありません